Skip to main content
SpringerLink
Log in

Molecular Staging of Cancer

  • Conference proceedings
  • © 2003

Overview

Editors:
  1. Heike Allgayer

    1. Dept. of Surgery, Klinikum Großhadern, Ludwig Maximilians Universität, München, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Markus M. Heiss

    1. Dept. of Surgery, Klinikum Großhadern, Ludwig Maximilians Universität, München, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Friedrich W. Schildberg

    1. Dept. of Surgery, Klinikum Großhadern, Ludwig Maximilians Universität, München, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 162)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 papers)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. Reviews

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. The Urokinase Receptor (uPAR, CD87) as a Target for Tumor Therapy: uPA-Silica Particles (SP-uPA) as a New Tool for Assessing Synthetic Peptides to interfere with uPA/uPA-Receptor Interaction

      • Elke Guthaus, Niko Schmiedeberg, Markus Bürgle, Viktor Magdolen, Horst Kessler, Manfred Schmitt
      Pages 3-14

    3. Molecular Regulation of Urokinase-Receptor Gene Expression as One Potential Concept for Molecular Staging and Therapy

      • Heike Allgayer
      Pages 15-30

    4. Stromal Cell Involvement in Cancer

      • Kasper Almholt, Morten Johnsen
      Pages 31-42

    5. Inhibition of the Tumor-Associated Urokinase-Type Plasminogen Activation System: Effects of High-Level Synthesis of Soluble Urokinase Receptor in Ovarian and Breast Cancer Cells in Vitro and in Vivo

      • Viktor Magdolen, Achim Krüger, Sumito Sato, Jutta Nagel, Stefan Sperl, Ute Reuning et al.
      Pages 43-63

    6. Molecular Mechanisms of Carcinogenesis in Gastric Cancer

      • Heinz Höfler, Karl-Friedrich Becker
      Pages 65-72

    7. Clinical Implications of Molecular Diagnosis in Hereditary Nonpolyposis Colorectal Cancer

      • Gabriela Möslein
      Pages 73-78

    8. Minimal Residual Disease in Gastric Cancer

      • Hendrik Seeliger, Hanno Spatz, Karl-Walter Jauch
      Pages 79-87

    9. Minimal Residual Disease in Breast Cancer and Gynecological Malignancies: Phenotype and Clinical Relevance

      • Frigga Roggel, Stefan Hocke, Kristina Lindemann, Sonja Sinz, Anita Welk, Martin Bosl et al.
      Pages 89-100

    10. Advanced Statistical Methods for the Definition of New Staging Models

      • Ronald Kates, Manfred Schmitt, Nadia Harbeck
      Pages 101-113

    11. Clinical Implications of the EGF Receptor/Ligand System for Tumor Progression and Survival in Gastrointestinal Carcinomas: Evidence for New Therapeutic Options

      • Reinhard Kopp, Elisabeth Rothbauer, Maximilian Ruge, Hans Arnholdt, Joachim Spranger, M. Muders et al.
      Pages 115-132

  3. Original Papers

    1. Front Matter

      Pages 133-133
      Download chapter PDF

    2. Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer

      • Joachim Bischoff, Robert Rosenberg, Michael Dahm, Wolfgang Janni, Klaus Gutschow
      Pages 135-140

    3. Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients

      • Nina Ditsch, Barbara Mayer, Michaela Rolle, Michael Untch, Friedrich Wilhelm Schildberg, Ilona Funke
      Pages 141-147

    4. Detection of Circulating Tumor Cells in Blood Using an Optimized Density Gradient Centrifugation

      • Ralf Gertler, Robert Rosenberg, Katrin Fuehrer, Michael Dahm, Hjalmar Nekarda, Joerg Ruediger Siewert
      Pages 149-155

    5. Antitumoral and Antimetastatic Effects of Continuous Particle-Mediated Cytokine Gene Therapy

      • Arne Dietrich, Katja Kraus, Ute Brinckmann, Christoph Stockmar, Anke Müller, Uwe Gerd Liebert et al.
      Pages 157-168

    6. Genetic Subtyping of Renal Cell Carcinoma by Comparative Genomic Hybridization

      • Kerstin Junker, Gregor Weirich, Mahul B. Amin, Petr Moravek, Winfried Hindermann, Joerg Schubert
      Pages 169-175

    7. Telomere Length and hTERT Expression in Patients with Colorectal Carcinoma

      • Robert Rosenberg, Ralf Gertler, Dominik Stricker, Silke Lassmann, Martin Werner, Hjalmar Nekarda et al.
      Pages 177-181

    8. Estimation of Concentration of Chosen Adhesive Factors in Suprarenal Tumours of “Incidentaloma” Type

      • Krzysztof Kołomecki, Henryk Stępień, Tomasz Stępień, Zbigniew Pasieka, Krzysztof Kuzdak
      Pages 183-188
Back to top

Keywords

About this book

An explosion of information has occurred since scientists began to define the molecular events that describe the malignant transformation and progression of cells and their development towards a life-threatening metastatic disease. The First International Congress on Molecular Staging of Cancer, held in Munich in December 2001, aimed to establish an international platform of exchange among molecular biologists, cell biologists, tumor immunologists, and clinical and surgical oncologists. This network approach should be fruitful for both clinicians and researchers. The highlighted topics included tumor-associated proteolysis, minimal residual disease, new approaches for molecular diagnosis and targeting, and the first molecular staging models. One session focused on technology transfer, opening up a new field of funding for innovative concepts. Finally, the impact of molecular staging on clinical strategies was discussed.

Editors and Affiliations

  • Dept. of Surgery, Klinikum Großhadern, Ludwig Maximilians Universität, München, Germany

    Heike Allgayer, Markus M. Heiss, Friedrich W. Schildberg

Bibliographic Information

  • Book Title: Molecular Staging of Cancer

  • Editors: Heike Allgayer, Markus M. Heiss, Friedrich W. Schildberg

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-59349-9

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2003

  • Softcover ISBN: 978-3-642-63945-6Published: 18 September 2011

  • eBook ISBN: 978-3-642-59349-9Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XI, 217

  • Topics: Cancer Research, Oncology

Publish with us

Policies and ethics

Back to top

Search

Navigation